NuSkin Enterprises NUS Impairment of strategic investments
Impairment of strategic investments at other companies
Other financials
Where this comes from
Reported directly by NuSkin Enterprises in its filing.
Tagged under the XBRL concept us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount.
The official record: NuSkin Enterprises’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about NuSkin Enterprises's impairment of strategic investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is NuSkin Enterprises's impairment of strategic investments?
- NuSkin Enterprises (NUS) reported impairment of strategic investments of $0 in Q1 2026.
- How has NuSkin Enterprises's impairment of strategic investments changed year-over-year?
- NuSkin Enterprises's impairment of strategic investments decreased by 100.0% year-over-year, from $28.08M to $0.
- What does impairment of strategic investments mean?
- This metric represents the impairment charges recognized on investments in equity securities that do not have a readily determinable fair value. It reflects the decline in value of strategic holdings or private equity investments that are deemed to be other-than-temporary. Frequent or large impairment charges may indicate poor capital allocation decisions or deteriorating performance within the company's investment portfolio.